PHILADELPHIA – Timothy H. Lucas, II, MD, PhD
, an assistant professor of Neurosurgery and director of the Translational Neuromodulation Lab
in the Perelman School of Medicine at the University of Pennsylvania,
has been awarded the 2017 Fellow in Leadership Award by Alpha Omega Alpha
national medical honor society. This annual fellowship is awarded to three mid-career physicians nationwide who exhibit outstanding leadership in their institutions. Alpha Omega Alpha provides one year of funding to winners as they explore creative, sustainable, and ethical modes of leadership. Penn Medicine will also match Lucas’ funding award.
“Leadership in an academic medical center requires development of skills outside of research and clinical excellence,” noted Sean Grady, MD, the Charles Harrison Frazier Professor of professor and chair of Neurosurgery. “Through the structure of the AOA fellowship, Dr. Lucas will have the opportunity to hone those skills – similar to what occurs in the best businesses today as exceptional individuals are identified for future leadership opportunities.”
During the one year fellowship, Lucas plans to divide his focus on interconnected topics, including examining the leadership styles of Penn Medicine executives, pursuing a master’s degree in the University of Pennsylvania’s inaugural Master of Health Care Innovation program, and exploring the business models of leading academic medical centers and health systems.
Addressing these topics marks a departure from Lucas’ typical research lab work on implantable devices that can restore body-brain communication following spinal cord injuries. However, the funding shortages academic physicians are facing motivated him to submit a proposal.
“I am honored to represent the University of Pennsylvania for this award,” Lucas said. “I look forward to working with our team of national thought leaders as we develop innovative business models for the future of healthcare.”
According to Lucas, the relationship between academic medical centers and health care corporations in the United States is both longstanding and symbiotic in nature, but it is also facing major challenges. Clinical revenues are strained as insurance reimbursements fall, funding for grants from the National Institutes of Health are becoming more competitive, and academic positions are being depleted. Ultimately, Lucas hopes to identify innovative business models that can provide a viable financial future for academic medical centers and hospitals alike.
“As the incoming president of Alpha Omega Alpha and chair of its Fellows in Leadership Committee, I can attest to the importance of this program – not only for its recipients, but for the future of healthcare in the United States,” said Eve Higginbotham SM, MD, vice dean for Inclusion and Diversity, senior fellow of the Leonard Davis Institute, and professor of Ophthalmology. “This award recognizes excellence in service leadership, and Dr. Lucas exemplifies those ideals. His project holds great promise in ensuring the future of academic medicine in an era focused on business metrics rather than research and education.”
Lucas’s other roles at Penn include directing the Neurosurgery Gene Therapy Program and the Penn Center for Laser Neurosurgery, serving as co-director of the Penn Center for Neuroengineering & Therapeutics, and the surgical director of the Penn Epilepsy Center. He received his medical degree from the University of Florida in 2001 and his doctorate from the University of Washington in 2009, where he also completed his residency. He served as Specialist Registrar in Neurological Surgery at St. George’s National Healthcare Trust in London, England from 2006 until 2007. He also completed fellowships in Neurological Oncology and Cerebrovascular Neurosurgery at the University of Washington in 2010, followed by a fellowship in Neurological Oncology Brain Mapping at the University of California San Francisco in 2011 before joining the Perelman School of Medicine at the University of Pennsylvania.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.9 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $496 million awarded in the 2020 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 44,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2020, Penn Medicine provided more than $563 million to benefit our community.